The growing prevalence of arthritis increase in traumatic injuries, growing prevalence of
spondylitis, increased research on joint health and joint conditions, and adoption of
technologically-advanced systems are the key factors for the market to grow. However,
factors such as high cost of diagnostics and treatment and surgical procedures are
expected to restrict the market growth during the forecast period. The global sacroiliitis
market is expected to witness tremendous growth during the forecast period.
Request Sample Copy:
The global sacroiliitis market is segmented on the basis of diagnosis, treatment, and
end-user. The sacroiliitis market, by diagnosis, is sub-segmented into imaging tests and
anesthetic injections. The imaging tests category includes X-ray, MRI, and CT scan. On
the basis of treatment, the market is categorized into medications, joint injections,
radiofrequency denervation, electrical stimulation, joint fusion, facet block, chiropractic
manipulation, and physical therapy. On the basis of end-user, the market is segmented
into hospitals and clinics, pharmacies, and diagnostic centers.
The Americas dominated the global sacroiliitis market in 2017. This can be attributed to
the increasing prevalence of arthritis, rising R&D activities for joint health, and
technological advancements within the region. According to the Centers for Disease
Control and Prevention in 2015, 54.4 million people in the Americas were affected by
doctor-diagnosed arthritis. The presence of major market players such as SI-BONE and
CoorsTek Medical LLC within the region also influences the market growth.
Europe (UK, Germany, France) is the second largest market owing to rapidly growing
work related joint disorders and increasing need for diagnostics. According to the
National Arthritis Week 2016 in the UK, 10 million people suffered from arthritis or
related conditions of which mo